enGene Holdings Inc. Warrants
NASDAQ Capital MarketTotal Valuation
enGene Holdings Inc. Warrants carries a market capitalization of 11.78M, placing it among publicly traded companies globally. Its enterprise value stands at -242.48M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 11.78M |
| Enterprise Value | -242.48M |
Share Statistics
enGene Holdings Inc. Warrants currently has 66.99M shares outstanding.
| Shares Outstanding | 66.99M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Financial Position
enGene Holdings Inc. Warrants maintains a current ratio of 11.75, meaning it holds 11.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 11.89, indicating elevated leverage, while an interest coverage ratio of -42.75 demonstrates limited ability to service its debt obligations.
| Current Ratio | 11.75 |
| Quick Ratio | 11.26 |
| Debt / Equity | 11.89 |
| Debt / EBITDA | -0.26 |
| Interest Coverage | -42.75 |
Financial Efficiency
| Return on Equity (ROE) | -53.16 |
| Return on Assets (ROA) | -39.30 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Taxes
| Income Tax | -18,000.00 |
| Effective Tax Rate | N/A |
Stock Price Statistics
enGene Holdings Inc. Warrants's stock has declined approximately -66.87302% over the past 52 weeks. The 50-day moving average sits at 1.97, while the 200-day moving average is 1.88.
| Beta (5Y) | N/A |
| 52-Week Price Change | -66.87302% |
| 50-Day Moving Average | 1.97 |
| 200-Day Moving Average | 1.88 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -127.14M, while operating income came in at -127.74M.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -127.74M |
| Pretax Income | -122.46M |
| Net Income | -122.44M |
| EBITDA | -127.14M |
| EBIT | -127.74M |
| Earnings Per Share (EPS) | N/A |
Balance Sheet
enGene Holdings Inc. Warrants holds 275.95M in cash and equivalents against 33.46M in total debt, resulting in a net debt position of -11.69M. Total book value stands at 230.21M, with working capital of 264.61M providing operational flexibility.
| Cash & Cash Equivalents | 275.95M |
| Total Debt | 33.46M |
| Net Debt | -11.69M |
| Equity (Book Value) | 230.21M |
| Book Value Per Share | N/A |
| Working Capital | 264.61M |
Cash Flow
enGene Holdings Inc. Warrants produced -102.45M in operating cash flow over the past twelve months.
| Operating Cash Flow | -102.45M |
| Capital Expenditures | -1.34M |
| Free Cash Flow | -103.78M |
| FCF Per Share | N/A |
Scores
enGene Holdings Inc. Warrants posts an Altman Z-Score of -1.98, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -1.98 |